Michael Dickenmann
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and .
Brune J, Dickenmann M, Sidler D, Walti L, Golshayan D, Manuel O, Haidar F, Neofytos D, Schnyder A, Boggian K, Müller T, Schachtner T, Khanna N, Schaub S, Wehmeier C, Swiss Transplant Cohort Study. Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and . Front Med (Lausanne) 2024; 11:1329778.
Feb 15, 2024Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and .
Feb 15, 2024Front Med (Lausanne) 2024; 11:1329778
Brune Jakob E, Dickenmann Michael, Sidler Daniel, Walti Laura N, Golshayan Délaviz, Manuel Oriol, Haidar Fadi, Neofytos Dionysios, Schnyder Aurelia, Boggian Katia, Müller Thomas F, Schachtner Thomas, Khanna Nina, Schaub Stefan, Wehmeier Caroline, Swiss Transplant Cohort Study
Surgical site infections after kidney transplantation are independently associated with graft loss.
Schreiber P, Hoessly L, Boggian K, Neofytos D, Van Delden C, Egli A, Dickenmann M, Hirzel C, Manuel O, Koller M, Rossi S, Banz V, Schmied B, Gürke L, Matter M, de Rougemont O, Bonani M, Golshayan D, Schnyder A, Sidler D, Haidar F, Kuster S, Stampf S, Müller N, members of the Swiss Transplant Cohort Study (STCS). Surgical site infections after kidney transplantation are independently associated with graft loss. Am J Transplant 2023
Nov 30, 2023Surgical site infections after kidney transplantation are independently associated with graft loss.
Nov 30, 2023Am J Transplant 2023
Schreiber Peter W, Hoessly Linard D, Boggian Katia, Neofytos Dionysios, Van Delden Christian, Egli Adrian, Dickenmann Michael, Hirzel Cédric, Manuel Oriol, Koller Michael, Rossi Simona, Banz Vanessa M, Schmied Bruno, Gürke Lorenz, Matter Maurice, de Rougemont Olivier, Bonani Marco, Golshayan Délaviz, Schnyder Aurelia, Sidler Daniel, Haidar Fadi, Kuster Stefan, Stampf Susanne, Müller Nicolas J., members of the Swiss Transplant Cohort Study (STCS)
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Mombelli M, Neofytos D, Huynh-Do U, Sánchez-Céspedes J, Stampf S, Golshayan D, Dahdal S, Stirnimann G, Schnyder A, Garzoni C, Venzin R, Magenta L, Schönenberger M, Walti L, Hirzel C, Munting A, Dickenmann M, Koller M, Aubert J, Steiger J, Pascual M, Müller T, Schuurmans M, Berger C, Binet F, Villard J, Müller N, Egli A, Cordero E, Van Delden C, Manuel O, Swiss Transplant Cohort Study. Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial. Clin Infect Dis 2023
Aug 16, 2023Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Aug 16, 2023Clin Infect Dis 2023
Mombelli Matteo, Neofytos Dionysios, Huynh-Do Uyen, Sánchez-Céspedes Javier, Stampf Susanne, Golshayan Délaviz, Dahdal Suzan, Stirnimann Guido, Schnyder Aurelia, Garzoni Christian, Venzin Reto M, Magenta Lorenzo, Schönenberger Melanie, Walti Laura N, Hirzel Cédric, Munting Aline, Dickenmann Michael, Koller Michael, Aubert John-David, Steiger Jürg, Pascual Manuel, Müller Thomas F, Schuurmans Macé M, Berger Christoph T, Binet Françoise-Isabelle, Villard Jean, Müller Nicolas J., Egli Adrian, Cordero Elisa, Van Delden Christian, Manuel Oriol, Swiss Transplant Cohort Study
Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
Hirzel C, Huynh-Do U, Golshayan D, Binet F, Müller T, Dickenmann M, Hadaya K, Sidler D, Walti L, Boggian K, Hirsch H, Van Delden C, Mombelli M, Manuel O, Mueller N, Surial B, Atkinson A, Projer L, Swiss Transplant Cohort Study (STCS). Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study. Transplantation 2022; 106:1875-1883.
Apr 1, 2022Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
Apr 1, 2022Transplantation 2022; 106:1875-1883
Hirzel Cédric, Huynh-Do Uyen, Golshayan Déla, Binet Françoise-Isabelle, Müller Thomas F, Dickenmann Michael, Hadaya Karine, Sidler Daniel, Walti Laura N, Boggian Katia, Hirsch Hans H, Van Delden Christian, Mombelli Matteo, Manuel Oriol, Mueller Nicolas J, Surial Bernard, Atkinson Andrew, Projer Lea, Swiss Transplant Cohort Study (STCS)
Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes.
Brune J, Schaub S, Khanna N, Schachtner T, Müller T, Boggian K, Schnyder A, Neofytos D, Hadaya K, Manuel O, Golshayan D, Walti L, Sidler D, Wehmeier C, Dickenmann M, Swiss Transplant Cohort Study. Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes. Am J Transplant 2022; 22:1823-1833.
Mar 26, 2022Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes.
Mar 26, 2022Am J Transplant 2022; 22:1823-1833
Brune Jakob E, Schaub Stefan, Khanna Nina, Schachtner Thomas, Müller Thomas, Boggian Katia, Schnyder Aurelia, Neofytos Dionysios, Hadaya Karine, Manuel Oriol, Golshayan Déla, Walti Laura, Sidler Daniel, Wehmeier Caroline, Dickenmann Michael, Swiss Transplant Cohort Study
Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study
Beerli N, De Geest S, Schnyder A, Huynh-Do U, Hadaya K, Golshayan D, Dickenmann M, Dahdal S, Binet F, Denhaerynck K, Mauthner O. Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study. Transpl Int 2022; 35:10076.
Jan 27, 2022Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study
Jan 27, 2022Transpl Int 2022; 35:10076
Beerli Nadine, De Geest Sabina M, Schnyder Aurelia, Huynh-Do Uyen, Hadaya Karine, Golshayan Délaviz, Dickenmann Michael, Dahdal Suzan, Binet Françoise-Isabelle, Denhaerynck Kris, Mauthner Oliver
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study
Perrottet N, Hopfer H, Venetz J, Aubert V, Buhler L, Steiger J, Manuel O, Pascual M, Golshayan D, Moll S, Rotman S, Fernández-Ruiz M, Binet F, Dickenmann M, Dahdal S, Hadaya K, Müller T, Schaub S, Koller M, the Swiss Transplant Cohort Study (STCS). Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study. PloS one 2021; 16:e0250829.
Apr 30, 2021Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study
Apr 30, 2021PloS one 2021; 16:e0250829
Perrottet Nancy, Hopfer Helmut, Venetz Jean-Pierre, Aubert Vincent, Buhler Leo, Steiger Jürg, Manuel Oriol, Pascual Manuel, Golshayan Déla, Moll Solange, Rotman Samuel, Fernández-Ruiz Mario, Binet Françoise-Isabelle, Dickenmann Michael, Dahdal Suzan, Hadaya Karine, Müller Thomas, Schaub Stefan, Koller Michael, the Swiss Transplant Cohort Study (STCS)
Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study
Krisl A, Dickenmann M, Koller M, Pascual M, Golshayan D, Hadaya K, Sidler D, Mueller T, Binet F, Hauri D, Stampf S, The Swiss Transplant Cohort Study Stcs. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study. Swiss Med Wkly 2020; 150:w20354.
Dec 5, 2020Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study
Dec 5, 2020Swiss Med Wkly 2020; 150:w20354
Krisl Andreas, Dickenmann Michael, Koller Michael, Pascual Manuel, Golshayan Déla, Hadaya Karine, Sidler Daniel, Mueller Thomas, Binet Françoise-Isabelle, Hauri Dimitri, Stampf Susanne, The Swiss Transplant Cohort Study Stcs
Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
Stenz N, Hofbauer G, Nägeli M, Mühlstädt M, Laffitte E, Hunger R, Harms M, Gaide O, Dickenmann M, Cozzio A, Arnold A, Stampf S, and The Swiss Transplant Cohort Study. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study). Dermatology 2020:1-11.
Nov 23, 2020Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
Nov 23, 2020Dermatology 2020:1-11
Stenz Nadja Angela, Hofbauer Günther F L, Nägeli Mirjam, Mühlstädt Michael, Laffitte Emmanuel, Hunger Robert E, Harms Mirjam, Gaide Olivier, Dickenmann Michael, Cozzio Antonio, Arnold Andreas W, Stampf Susanne, and The Swiss Transplant Cohort Study
Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland
Steiner R, The Swiss Transplant Cohort Study Stcs, Koller M, Haralamvieva E, Cogliatti S, Binet F, Tinguely M, Fehr T, de Leval L, Schuurmans M, Dickenmann M, Manuel O, Mueller N, Achermann R, McKee T, Giostra E, Kridel R, Dietrich P. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland. Swiss Med Wkly 2018; 148:w14596.
Mar 8, 2018Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland
Mar 8, 2018Swiss Med Wkly 2018; 148:w14596
Steiner Raphael, The Swiss Transplant Cohort Study Stcs, Koller Michael, Haralamvieva Eugenia, Cogliatti Sergio, Binet Françoise-Isabelle, Tinguely Marianne, Fehr Thomas, de Leval Laurence, Schuurmans Macé M, Dickenmann Michael, Manuel Oriol, Mueller Nicolas, Achermann Rita, McKee Thomas, Giostra Emiliano, Kridel Robert, Dietrich Pierre-Yves
ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study
Mauthner O, De Geest S, Calciolari S, Huynh-Do U, Hadaya K, Golshayan D, Dickenmann M, Binet F, Engberg S, Walston J, Claes V, GERAS study consortium; For the Psychosocial Interest Group; Swiss Transplant Cohort Study (STCS). ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study. J Adv Nurs 2016; 73:716-734.
Nov 23, 2016ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study
Nov 23, 2016J Adv Nurs 2016; 73:716-734
Mauthner Oliver, De Geest Sabina, Calciolari Stefano, Huynh-Do Uyen, Hadaya Karine, Golshayan Déla, Dickenmann Michael, Binet Françoise-Isabelle, Engberg Sandra, Walston Jeremy, Claes Veerle, GERAS study consortium; For the Psychosocial Interest Group; Swiss Transplant Cohort Study (STCS)
Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment
Stern M, Dickenmann M, Mueller N, Boggian K, Meylan P, Manuel O, Van Delden C, Cusini A, Hirsch H. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation 2014; 98:1013-8.
Nov 15, 2014Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment
Nov 15, 2014Transplantation 2014; 98:1013-8
Stern Martin, Dickenmann Michael, Mueller Nicolas J, Boggian Katia, Meylan Pascal, Manuel Oriol, Van Delden Christian, Cusini Alexia, Hirsch Hans
The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss Experience
Schiesser M, Steinemann D, Hadaya K, Huyen-Do U, Eisenberger U, Binet F, Fehr T, Dickenmann M. The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss Experience. Transplantation 2014
Oct 21, 2014The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss Experience
Oct 21, 2014Transplantation 2014
Schiesser Marc, Steinemann Daniel C, Hadaya Karine, Huyen-Do Uyen, Eisenberger Ute, Binet Françoise-Isabelle, Fehr Thomas, Dickenmann Michael
ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
Kim M, Tsinalis D, Franz S, Binet F, Gürke L, Mihatsch M, Steiger J, Thiel G, Dickenmann M. ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial. Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7.
Jan 1, 2008ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
Jan 1, 2008Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7
Kim Min Jeong, Tsinalis Dimitrios, Franz Stefan, Binet Françoise-Isabelle, Gürke Lorenz, Mihatsch Michael J, Steiger Jürg, Thiel Gilbert, Dickenmann Michael
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients
Schiesser D, Binet F, Tsinalis D, Dickenmann M, Keusch G, Schmidli M, Ambühl P, Lüthi L, Wüthrich R. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006; 21:2841-5.
Oct 1, 2006Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients
Oct 1, 2006Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006; 21:2841-5
Schiesser Daniela, Binet Françoise-Isabelle, Tsinalis Dimitrios, Dickenmann Michael, Keusch Gérald, Schmidli Markus, Ambühl Patrice M, Lüthi Liudmila, Wüthrich Rudolf P
Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin
Tsinalis D, Dickenmann M, Brunner F, Gürke L, Mihatsch M, Nickeleit V. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. American journal of kidney diseases : the official journal of the National Kidney Foundation 2002; 40:667-70.
Sep 1, 2002Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin
Sep 1, 2002American journal of kidney diseases : the official journal of the National Kidney Foundation 2002; 40:667-70
Tsinalis Dimitrios, Dickenmann Michael, Brunner Felix, Gürke Lorenz, Mihatsch Michael, Nickeleit Volker